Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluerock Homes Trust (BHM) Liabilities and Shareholders Equity (2021 - 2025)

Bluerock Homes Trust's Liabilities and Shareholders Equity history spans 5 years, with the latest figure at $222.1 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 72.26% year-over-year to $222.1 million; the TTM value through Dec 2025 reached $628.7 million, down 80.66%, while the annual FY2024 figure was $967.0 million, 43.98% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $222.1 million at Bluerock Homes Trust, up from $220.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $967.0 million in Q4 2024 and bottomed at $186.2 million in Q1 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $668.3 million (2023), against an average of $606.4 million.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 43.98% in 2024 before it tumbled 74.4% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $541.5 million in 2021, then grew by 21.69% to $658.9 million in 2022, then rose by 1.93% to $671.6 million in 2023, then surged by 43.98% to $967.0 million in 2024, then crashed by 77.03% to $222.1 million in 2025.
  • Per Business Quant, the three most recent readings for BHM's Liabilities and Shareholders Equity are $222.1 million (Q3 2025), $220.3 million (Q2 2025), and $186.2 million (Q1 2025).